Durable Response to Brentuximab Vedotin-Based Chemotherapy in Refractory Hodgkin Lymphoma with Central Nervous System (CNS) Involvement

Patient: Female, 29-year-old Final Diagnosis: Refractory Hodgkin lymphoma with CNS involvement Symptoms: Blurred vision Medication: — Clinical Procedure: — Specialty: Hematology OBJECTIVE: Rare disease BACKGROUND: CNS involvement in Hodgkin lymphoma is rare. Despite various treatment options, median...

Descripción completa

Detalles Bibliográficos
Autores principales: Mociková, Heidi, Malikova, Hana, Holesta, Michal, Elturki, Abdulfattah, Campr, Vit, Kozak, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083218/
https://www.ncbi.nlm.nih.gov/pubmed/32170052
http://dx.doi.org/10.12659/AJCR.921657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083218/
https://www.ncbi.nlm.nih.gov/pubmed/32170052
http://dx.doi.org/10.12659/AJCR.921657

Ejemplares similares